1)大腸癌研究会(編):大腸癌治療ガイドライン 医師用 2016年版,金原出版,2016
2)Shimada Y, Yoshino M, Wakui A, et al:Phase Ⅱ study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. J Clin Oncol 11:909-913, 1993
3)佐藤田鶴子,吉成伯夫,岩重洋介:口腔粘膜疾患に対する半夏瀉心湯の使用経験.日口腔外会誌35:1268-1272,1989
4)枝松 満:口腔粘膜疾患に対する黄連湯の臨床効果.漢方診療7:54-56,1988
5)坂田 優,鈴木秀和,鎌滝哲也:塩酸イリノテカンの下痢に対する半夏瀉心湯の効果.癌と化療21:1241-1244,1994
6)森 清志:これまでの研究と今後の展望 半夏瀉心湯:総論 塩酸イリノテカンの下痢に対する半夏瀉心湯のRCTによるエビデンス.漢方医学35:133-134,2011
7)田中哲二:症例から考える塩酸イリノテカン治療に伴う下痢と半夏潟心湯の効果.漢方医学24:178-182,2000
8)鎌滝 哲:塩酸イリノテカンの副作用である遅延性下痢の半夏潟心湯による予防.血腫瘍49:505-509,2004
9)Kase Y, Hayakawa T, Aburada M, et al:Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat. Jpn J Pharmacol 75:407-413, 1997
10)Yokoi T, Narita M, Nagai E, et al:Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate. Jpn J Cancer Res 86:985-989, 1995
11)高橋 誠,緒方憲太郎,高瀬久光,他:塩酸イリノテカンの下痢に対する半夏潟心立+酸化マグネシウム併用投与の有用性.日病薬師会誌44:1099-1101,2008
12)de Gramont A, Figer A, Seymour M, et al:Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Clin Oncol 18:2938-2947, 2000
13)Cersosimo RJ:Oxaliplatin-associated neuropathy:a review. Ann Pharmacother 39:128-135, 2005
14)Grothey A:Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 5(Suppl 1):S 38-46, 2005
15)Graham MA, Lockwood GF, Greenslade D, et al:Clinical pharmacokinetics of oxaliplatin:a critical review. Clin Cancer Res 6:1205-1218, 2000
16)Ta LE, Espeset L, Podratz J, et al:Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27:992-1002, 2006
17)後藤和宏:牛車腎気丸の抗侵害受容作用機序 ダイノルフィンと一酸化窒素の関与.ペインクリニック19:1179-1185,1998
18)Nishioka M, Shimada M, Kurita N, et al:The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol 16:322-327, 2011
19)関川浩司,中山幹大,岩泉清久,他:アンケート調査からみた外科領域における漢方薬の使用状況と今後の展開.Prog Med 31:173-177,2011
20)Shibata C, Sasaki I, Naito H, et al:The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs. Surgery 126:918-924, 1999
21)Nagano T, Itoh H, Takeyama M, et al:Effect of Dai-kenchu-to on levels of 3 brain-gut peptides(motilin, gastrin and somatostatin)in human plasma. Biol Pharm Bull 22:1131-1133, 1999
22)Satoh K, Hayakawa T, Kase Y, et al:Mechanisms for contractile effect of Dai-kenchu-to in isolated guinea pig ileum. Dig Dis Sci 46:250-256, 2001
23)Sato Y, Katagiri F, Inoue S, et al:Dai-kenchu-to raises levels of calcitonin gene-related peptide and substance P in human plasma. Biol Pharm Bull 27:1875-1877, 2004
24)Kono T, Koseki T, Chiba S, et al:Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1. J Surg Res 150:78-84, 2008
25)Kono T, Kaneko A, Hira Y, et al:Anti-colitis and-adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model. J Crohns Colitis 4:161-170, 2010
26)Shimada M, Morine Y, Nagano H, et al:Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer:a multi-center, phase III trial(JFMC40-1001). Int J Clin Oncol 20:95-104, 2015
27)Kono T, Kaneko A, Hira Y, et al:Anti-colitis and-adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model. J Crohns Colitis 4:161-170, 2010
28)Yaegashi M, Otsuka K, Itabashi T, et al:Daikenchuto stimulates colonic motility after laparoscopic-assisted colectomy. Hepatogastroenterology 61:85-89, 2014
29)寺澤捷年,喜多敏明,嶋田 豊,他:桃核承気湯加味方が奏効したアトピー性皮膚炎の4症例.日東洋医誌46:45-54,1995
30)福冨理香,平田武臣:肥満治療の実際.東方医学23:45-49,2007
31)西田愼二,西本 隆,保田佳苗,他:自閉症児の衝動性に桃核承気湯と甘麦大棗湯が有効であった1例.日東洋心身医研19:59-61,2005